# US 2017/0253897 A1 · Methods for making l-glufosinate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0253897 A1
- Document ID: US20170253897A1
- Status: Published application
- Kind: A1
- Application number: 15/445,254
- Filed: 2017-02-28
- Published: 2017-09-07
- Earliest claimed: 2016-03-02
- Assignees: AgriMetis, LLC
- Applicants: AgriMetis, LLC
- Inventors: Brian Michael Green; Michelle Lorraine Gradley
- Web page: https://patentgrep.com/patent/US20170253897A1

## CPC

- C12P 13/02: Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)}
- A01N 25/30: characterised by the surfactants
- A01N 57/20: containing acyclic or cycloaliphatic radicals
- C12N 1/20: Bacteria; Culture media therefor
- C12N 9/10: Transferases (2.) (ribonucleases C12N9/22)
- C12P 9/00: Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen {(phosphoglycerides, C12P7/6481)}
- C12P 13/04: Alpha- or beta- amino acids {(other amino acids C12P13/005)}
- C12P 41/00: Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12Y 104/03003: D-Amino-acid oxidase (1.4.3.3)
- C12Y 206/01019: 4-Aminobutyrate—2-oxoglutarate transaminase (2.6.1.19)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

Methods for the production of L-glufosinate (also known as phosphinothricin or (S)-2-amino-4-(hydroxy(methyl)phosphonoyl)butanoic acid) are provided. The methods comprise a two-step process. The first step involves the oxidative deamination of D-glufosinate to PPO (2-oxo-4-(hydroxy(methyl)phosphinoyl)butyric acid). The second step involves the specific amination of PPO to L-glufosinate, using an amine group from one or more amine donors. By combining these two reactions, the proportion of L-glufosinate in a mixture of L-glufosinate and D-glufosinate can be substantially increased.

## Claims

### Claim 1

A method for making L-glufosinate, comprising:
reacting D-glufosinate with a D-amino acid oxidase (DAAO) enzyme to form PPO (2-oxo-4-(hydroxy(methyl)phosphinoyl)butyric acid); and
aminating the PPO to L-glufosinate by a transaminase (TA) enzyme, using an amine group from one or more amine donors,
wherein at least 70% of the D-glufosinate is converted to L-glufosinate.

### Claim 2 (depends on 1)

The method of claim 1, wherein the amine donor is selected from the group consisting of glutamate, L-glutamate, alanine, sec-butylamine, phenylethylamine, glycine, lysine, valine, serine, glutamine, isopropylamine, ethanolamine, 2-aminobutyric acid, diaminoproprionic acid, or any secondary amine or amino acid.

### Claim 3 (depends on 1)

The method of claim 1, wherein the D-glufosinate is originally present in a racemic mixture of D- and L-glufosinate or salts thereof.

### Claim 4 (depends on 1)

The method of claim 1, wherein the DAAO enzyme is a mutant DAAO comprising one or more mutations at positions 54, 56, 58, 213, and 238, wherein the mutation at position 54 is selected from the group consisting of N54C, N54L, N54T, and N54V; the mutation at position 56 is T56M; and the mutation at position 58 is selected from the group consisting of F58A, F58G, F58H, F58K, F58N, F58Q, F58R, F58S, and F58T.

### Claim 5 (depends on 4)

The method of claim 4, wherein the mutations comprise N54V, F58Q, and M213S.

### Claim 6 (depends on 1)

The method of claim 1, wherein the TA enzyme is an enzyme encoded by SEQ ID NO: 1.

### Claim 7 (depends on 1)

The method of claim 1, wherein the TA enzyme is a GabT transaminase having UniProt No. P22256.

### Claim 8 (depends on 1)

The method of claim 1, wherein the reacting step and the aminating step are performed in a single container.

### Claim 9 (depends on 8)

The method of claim 8, wherein all reagents are substantially added at the start of the reaction.

### Claim 10 (depends on 8)

The method of claim 8, wherein the reagents for the reacting step and the reagents for the aminating step are added to the single container at different times.

### Claim 11 (depends on 1)

The method of claim 1, wherein the reacting step and the aminating step are performed in separate containers.

### Claim 12

A composition comprising D-glufosinate, PPO, and L-glufosinate.

### Claim 13 (depends on 12)

The composition of claim 12, wherein the amount of L-glufosinate is 90% or greater based on the total amount of D-glufosinate, PPO, and L-glufosinate.

### Claim 14

A formulation, comprising:
L-glufosinate ammonium in an amount from 10-30% by weight of the formulation;
one or more additional components selected from the group consisting of sodium alkyl ether sulfate in an amount from 10-40% by weight of the formulation; 1-methoxy-2-propanol in an amount from 0.5-2% by weight of the formulation; dipropylene glycol in an amount from 0-18% by weight of the formulation; and alkyl polysaccharide in an amount from 3-20% by weight of the formulation; and
water as the balance of the formulation.

### Claim 15 (depends on 14)

The formulation of claim 14, wherein the formulation comprises:
L-glufosinate ammonium in an amount of 12.25% by weight of the formulation;
sodium alkyl ether sulfate in an amount of 31.6% by weight of the formulation;
1-methoxy-2-propanol in an amount of 1% by weight of the formulation;
dipropylene glycol in an amount of 8.6% by weight of the formulation;
alkyl polysaccharide in an amount of 9.8% by weight of the formulation; and
water in an amount of 36.75% by weight of the formulation.

### Claim 16 (depends on 14)

The formulation of claim 14, wherein the formulation comprises:
L-glufosinate ammonium in an amount of 24.5% by weight of the formulation;
sodium alkyl ether sulfate in an amount of 31.6% by weight of the formulation;
1-methoxy-2-propanol in an amount of 1% by weight of the formulation;
dipropylene glycol in an amount of 8.6% by weight of the formulation;
alkyl polysaccharide in an amount of 9.8% by weight of the formulation; and
water in an amount of 24.5% by weight of the formulation.

### Claim 17 (depends on 14)

The formulation of claim 14, wherein the formulation comprises:
L-glufosinate ammonium in an amount of 12.25% by weight of the formulation;
sodium alkyl ether sulfate in an amount of 15.8% by weight of the formulation;
1-methoxy-2-propanol in an amount of 0.5% by weight of the formulation;
dipropylene glycol in an amount of 4.3% by weight of the formulation;
alkyl polysaccharide in an amount of 4.9% by weight of the formulation; and
water in an amount of 62.25% by weight of the formulation.

### Claim 18 (depends on 14)

The formulation of claim 14, wherein the formulation comprises:
L-glufosinate ammonium in an amount of 12.25% by weight of the formulation;
sodium alkyl ether sulfate in an amount of 22.1% by weight of the formulation;
1-methoxy-2-propanol in an amount of 1% by weight of the formulation;
alkyl polysaccharide in an amount of 6.2% by weight of the formulation; and
water in an amount of 58.45% by weight of the formulation.

### Claim 19 (depends on 14)

The formulation of claim 14, wherein the formulation comprises:
L-glufosinate ammonium in an amount of 24.5% by weight of the formulation;
sodium alkyl ether sulfate in an amount of 22.1% by weight of the formulation;
1-methoxy-2-propanol in an amount of 1% by weight of the formulation;
alkyl polysaccharide in an amount of 6.2% by weight of the formulation; and
water in an amount of 46.2% by weight of the formulation.

### Claim 20 (depends on 14)

The formulation of claim 14, wherein the formulation comprises:
L-glufosinate ammonium in an amount of 12.25% by weight of the formulation;
sodium alkyl ether sulfate in an amount of 11.05% by weight of the formulation;
1-methoxy-2-propanol in an amount of 0.5% by weight of the formulation;
alkyl polysaccharide in an amount of 3.1% by weight of the formulation; and
water in an amount of 73.1% by weight of the formulation.
